Scleroderma and African Americans
What is the incidence and prevalence of scleroderma in African American patients?
Among all African Americans, 23.7 people per million are diagnosed with systemic sclerosis, while the comparable rate among non-African Americans is 18.3 people per million diagnosed. We see a similar pattern when looking at the prevalence of 315 of every one million African Americans diagnosed with systemic sclerosis. In contrast, 225 of every one million non-African Americans are diagnosed with systemic sclerosis.
What is the difference in disease progression between an African American patient and a non-African American patient?
How do symptoms among African American patients compare to symptoms of non-African American patients?
Raynaud Phenomenon is also not as obvious and may even be less severe than it could be in a non-African American patient. More severe G.I. tract involvement and muscle disease is more commonly seen in African American patients.
Inspire is an online community where people share experiences and provide mutual support. The Scleroderma Foundation community on Inspire is nearly 40,000 individuals who discuss a range of topics. The conversation never ends and it's always online. What do you want to talk about today?
Resources for Newly Diagnosed
Visit the "Resources" page to find an extensive list of information that ranges from ways to connect with others dealing with the same issues as you, or referrals to organizations that provide assistance to pay for medication or to heat your home, and assorted reading lists of helpful materials.
Watch hundreds of videos on the Scleroderma Foundation's YouTube channel that cover a range of topics from managing scleroderma symptoms to research trends, and more.